Thank you for sharing!

Your article was successfully shared with the contacts you provided.
A Zofran pill, manufactured by GlaxoSmithKline Plc, is pictured in its packaging at a Walgreen's pharmacy in the Brooklyn borough of New York on Tuesday, September 23, 2003. Zofran is an anti-nausea medication for cancer patients undergoing chemotherapy. Drug makers are betting that the market for treating cancer side effects has room to expand. Photographer: Michael Nagle/Bloomberg News A Zofran pill, manufactured by GlaxoSmithKline Plc, is pictured in its packaging at a Walgreen’s pharmacy in the Brooklyn borough of New York. Photo: Michael Nagle/Bloomberg News

A federal judge overseeing the multidistrict litigation alleging anti-nausea Zofran caused birth defects has indefinitely canceled the first bellwether trial this week due to the coronavirus.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Amanda Bronstad

Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She writes the email dispatch Critical Mass. She is based in Los Angeles.

More from this author


Product LiabilityBook

This book analyzes the theory and practice of products liability litigation, whether the issue is drugs, food, chemicals, or any of the 100s of other products that may b...

Get More Information

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.